Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Public Econ. 2016 Nov 23;145:181–200. doi: 10.1016/j.jpubeco.2016.11.010

Table 1.

Summary Statistics

Premarket Applications (PMAs) - Devices: N=847
Premarket Applications (Cardiovascular Devices): N=241

Devices CV Devices Only
Mean S.D. Mean S.D.
Approval Time (Months) 18.12 15.84 17.31 12.96
Approval Time (First Product) 21.48 16.77 23.07 18.16
Approval Time Ratio: First Device/Average Device 1.18 1.06 1.33 1.40
Entry Order 6.37 8.79 5.06 4.32
Priority Review 0.10 0.30 0.10 0.29
New Applications (Current) 15.32 20.63 27.57 25.92
Submission Year 1994 8.46 1995 7.98
Firm 32 FEs 15 FEs
Medical Device Product Code 249 FEs 55 FEs

Summary statistics for the 847 medical devices used in the empirical analyses as well as separate descriptive statistics (right columns) for the subset of (241) cardiovascular devices alone. Approval Time measures months from PMA submission until FDA approval. Entry Order is based on the chronological ordering of PMA submissions. Priority Review is an indicator for whether a product was eligible for expedited FDA review. New Applications (Current) is a firm-specific, time-varying count of total successful new product applications that the applicant firm has completed at the time of a given submission. Submission year is the calendar year in which an application was sent to the FDA. Firm contains a set of dummy variables for each firm in the data set or a dummy indicator for being a “small” firm – i.e. one with fewer than five new applications over the entire period of observation.